Bernard Slater Jr.: Hope on the Horizon as Hemophilia B Treatment Continues to Evolve
Bernard Slater Jr., Business and Community Liaison at Charleston Job Corps Center, shared on LinkedIn:
”Yesterday I had an appointment with my hematologist, Dr. Merrill, to discuss my Hemophilia B, recent injuries, and some of the newer treatment options that are becoming available.
We spent quite a bit of time talking about gene therapy, specifically Hemgenix.
While it doesn’t appear that I would currently qualify for gene therapy, and insurance would likely not approve it in my case, I appreciated having an honest conversation about where things stand and what options may be available in the future.
One thing my doctor was concerned about was the number of falls and injuries I’ve experienced over the past year.
Between a broken rib (3-legged race w Preston), a tailbone injury(slipped on ice and fell down the stairs), and my recent hip hematoma, he wanted to take a closer look and ordered additional testing and blood work.
The encouraging news is that there are still new treatment options available.
For now, I will continue on Alprolix, and my doctor is seeking insurance approval for Hympavzi, a once-weekly injection for people with Hemophilia B.
If approved, it could help provide additional protection and reduce bleeding episodes.
If it’s not approved by my insurance , the we’ll explore other options like regular prophylactic treatments.
Living with a bleeding disorder often means adapting to setbacks, adjusting plans and schedules, and learning about new therapies as they become available.
While yesterday didn’t bring all the answers I was hoping for, it did give me a clearer path forward.
I’m grateful for the advances being made in hemophilia care and for the medical professionals who continue working to improve the quality of life for people like us.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering